NAOMI MORSON: Open Payments
NPI 1487138863 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 34 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $490 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $118 |
| Astellas Pharma US Inc | 4 | $103 |
| Lilly USA, LLC | 4 | $77 |
| PFIZER INC. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Dexcom, Inc. | 1 | $40 |
| ABBVIE INC. | 2 | $39 |
| Exact Sciences Corporation | 1 | $24 |
Products named: Veozah, MOUNJARO, GEMTESA, FARXIGA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, VRAYLAR, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
